M2698

CAS No. 1379545-95-5

M2698( —— )

Catalog No. M33004 CAS No. 1379545-95-5

M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 119 In Stock
5MG 102 In Stock
10MG 164 In Stock
25MG 330 In Stock
50MG 465 In Stock
100MG 642 In Stock
200MG 864 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    M2698
  • Note
    Research use only, not for human use.
  • Brief Description
    M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity.
  • Description
    M2698 (MSC2363318A) is an orally active, ATP competitive, selective p70S6K and Akt dual-inhibitor with IC50s of 1 nM for p70S6K, Akt1 and Akt3. M2698 can cross the blood-brain barrier and has anti-cancer activity.
  • In Vitro
    Cell Proliferation AssayCell Line:Breast tumors cell lines Concentration:0.3 nM to 50 M Incubation Time:72 hours Result:Inhibited proliferation in a dose-dependent manner.Western Blot Analysis Cell Line:HCC1419 and MDA-MB-453 cells Concentration: 0.3, 1 μM Incubation Time:24 hours Result:Inhibited p70S6K activity and induced feedback loop phosphorylation on Akt and suppressed Akt activity in breast cancer cell lines.
  • In Vivo
    Animal Model:Female nude mice bearing MDA-MB-468 tumorsDosage:10, 20 and 30 mg/kg Administration:PO; daily; for 28 days Result:Resulted in dose-dependent inhibition of tumor growth and resulted in tumor regression with the highest dose of 30 mg/kg.Animal Model:Female SCID Beige mice with MDA-MB-453 xenografted Dosage:20 mg/kg (Pharmacokinetic Analysis) Administration:Daily; for 4 days Result:Had a tumor:plasma exposure ratio of 12:1 over 24 hours.
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Akt
  • Recptor
    Akt | mTOR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1379545-95-5
  • Formula Weight
    449.86
  • Molecular Formula
    C21H19ClF3N5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (277.86 mM; Ultrasonic )
  • SMILES
    N([C@H](CN1CCC1)C2=CC(C(F)(F)F)=C(Cl)C=C2)C=3C4=C(C(C(N)=O)=CC=C4)N=CN3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Machl A, et al. M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier. Am J Cancer Res. 2016 Mar 15;6(4):806-18.?
molnova catalog
related products
  • Honokiol

    Honokiol (0, 12.5, 25 and 50 μM) inhibits the growth of GBM cells and induces apoptosis, with IC50 of appr against 30 μM DBTRG-05MG cell.

  • YS-67

    YS-67 is an orally available, selective and potent EGFR inhibitor with antitumor activity, inhibits p-EGFR and p-AKT, and inhibits the proliferation of A549, PC-9, and A431 cells.

  • NSC 86429

    SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively).